Xi'an International Medical Investment Company Limited (SHE:000516)
China · Delayed Price · Currency is CNY 4.400
+0.020 (0.46%)
Oct 30, 2026, 3:05 PM CST
SHE:000516 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Revenue | 4,033 | 3,948 | 4,741 | 4,506 | 2,662 | 2,901 |
Other Revenue | 126.71 | 126.71 | 74.31 | 111.85 | 48.47 | 20.62 |
| 4,160 | 4,075 | 4,815 | 4,618 | 2,711 | 2,921 | |
Revenue Growth | -1.06% | -15.39% | 4.28% | 70.34% | -7.20% | 81.78% |
Cost of Revenue | 3,624 | 3,757 | 4,389 | 4,200 | 2,913 | 2,891 |
Gross Profit | 536.47 | 317.59 | 426.31 | 418.28 | -201.57 | 30.23 |
Selling, General & Admin | 538.96 | 551.19 | 548.11 | 646.85 | 632.67 | 656.76 |
Research & Development | 7.49 | 7.63 | 6.99 | 9.81 | 15.51 | 12.8 |
Other Operating Expenses | 65.99 | 62.41 | 61.56 | 68.94 | 38.61 | 28.6 |
Operating Expenses | 607.23 | 613.6 | 622.41 | 741.14 | 693.73 | 704.09 |
Operating Income | -70.76 | -296.02 | -196.1 | -322.86 | -895.3 | -673.87 |
Interest Expense | -137.89 | -137.89 | -173.35 | -219.03 | -190.53 | -190.77 |
Interest & Investment Income | 20.24 | 37.8 | 7.96 | 81.27 | 28.94 | 59.87 |
Currency Exchange Gain (Loss) | - | - | - | 1.12 | -3.7 | 0.43 |
Other Non Operating Income (Expenses) | 7.49 | -2.04 | -10.26 | -13.03 | -7.51 | -5.59 |
EBT Excluding Unusual Items | -180.93 | -398.14 | -371.76 | -472.54 | -1,068 | -809.93 |
Gain (Loss) on Sale of Investments | 1.34 | -5.98 | 23.77 | 2.1 | -80.79 | -104.36 |
Gain (Loss) on Sale of Assets | -0.11 | 0.18 | 1.66 | 1.95 | 7.25 | -0.17 |
Asset Writedown | 0.32 | -0.25 | -2.59 | -0.87 | -3.36 | -1.9 |
Other Unusual Items | 3.16 | 3.89 | 4.28 | 2.11 | 4.69 | -3.21 |
Pretax Income | -176.22 | -400.3 | -344.64 | -467.25 | -1,140 | -919.57 |
Income Tax Expense | 17.49 | 20.73 | 20.5 | 4.69 | 55.03 | -74.43 |
Earnings From Continuing Operations | -193.71 | -421.03 | -365.14 | -471.95 | -1,195 | -845.14 |
Minority Interest in Earnings | 103.9 | 107.95 | 111.01 | 103.59 | 18.66 | 22.97 |
Net Income | -89.8 | -313.08 | -254.13 | -368.36 | -1,177 | -822.17 |
Net Income to Common | -89.8 | -313.08 | -254.13 | -368.36 | -1,177 | -822.17 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 2,226 | 2,236 | 2,310 | 2,302 | 2,263 | 2,222 |
Shares Outstanding (Diluted) | 2,226 | 2,236 | 2,310 | 2,302 | 2,263 | 2,222 |
Shares Change | -4.65% | -3.20% | 0.35% | 1.74% | 1.84% | -2.03% |
EPS (Basic) | -0.04 | -0.14 | -0.11 | -0.16 | -0.52 | -0.37 |
EPS (Diluted) | -0.04 | -0.14 | -0.11 | -0.16 | -0.52 | -0.37 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 1,097 | 1,014 | 461.38 | 324.66 | -726.51 | -1,203 |
Free Cash Flow Per Share | 0.49 | 0.45 | 0.20 | 0.14 | -0.32 | -0.54 |
Gross Margin | 12.90% | 7.79% | 8.85% | 9.06% | -7.43% | 1.03% |
Operating Margin | -1.70% | -7.27% | -4.07% | -6.99% | -33.02% | -23.07% |
Profit Margin | -2.16% | -7.68% | -5.28% | -7.98% | -43.41% | -28.15% |
Free Cash Flow Margin | 26.36% | 24.89% | 9.58% | 7.03% | -26.80% | -41.20% |
EBITDA | 557.59 | 376.13 | 534.44 | 447.03 | -274.98 | -105.23 |
EBITDA Margin | 13.40% | 9.23% | 11.10% | 9.68% | -10.14% | -3.60% |
D&A For EBITDA | 628.35 | 672.15 | 730.54 | 769.89 | 620.31 | 568.64 |
EBIT | -70.76 | -296.02 | -196.1 | -322.86 | -895.3 | -673.87 |
EBIT Margin | -1.70% | -7.27% | -4.07% | -6.99% | -33.02% | -23.07% |
Revenue as Reported | 4,160 | 4,075 | 4,815 | 4,618 | 2,711 | 2,921 |
Advertising Expenses | - | 23.39 | 27.2 | 29.65 | 16.62 | 34.92 |